The FDA today updated on a previous voluntary recall of Asahi Kasei (TYO:3407) subsidiary Zoll Medical‘s LifeVest wearable automatic external defibrillators over errors that can cause the device to stop functioning, saying the company has initiated new customer training on the device and is working on a software fix. In January, the FDA released a warning and […]
TherOx said today it completed a new round of debt financing led by Asahi Kasei (TYO:3407) subsidiary Zoll Medical for an undisclosed amount. Funds from the deal will be used to support the US market introduction and commercialization of the Irvine, Calif.-based company’s SuperSaturated Oxygen Therapy system designed to treat patients with acute myocardial infarction once the system […]
Asahi Kasei (TYO:3407) subsidiary Zoll Medical is facing a revived suit alleging that the company’s LifeVest failed to appropriately shock a patient’s heart, resulting in her death. The case was filed by Dennis Godelia, remaining son of deceased Debra Godelia, who died in 2013 after the LifeVest allegedly did not function correctly during a “defibrillation event,” court documents […]
Asahi Kasei (TYO:3407) subsidiary Zoll Medical and the FDA are warning about an error code displayed by a model of its LifeVest wearable automatic external defibrillator that was involved in a patient’s death. Patients using LifeVest 4000 models who don’t contact the company after the device displays “Call for service: Device has a problem that may […]
Japan’s Asahi Kasei Corp. (TYO:3407), which in 2012 paid $2.3 billion to acquire Zoll Medical, is shuffling the deck at the resuscitation device maker. Former CEO Rick Packer, who led Zoll for 13 years before overseeing the merger with Asahi Kasei, was promoted to primary executive officer and charged with building the healthcare business into “a 3rd […]
Zoll Medical said today that it won Shonin approval from the Japanese Ministry of Health, Labor & Welfare for its R Series combination monitor and automated external defibrillator.
The new automated external defibrillator allows emergency responders to pre-program a shock instead of pushing the “shock” button.
Japan’s Ministry of Health, Labour and Welfare granted Shonin approval to Zoll Medical‘s intravascular temperature managment device for treating patients with high fevers and brain damage.
The Chelmsford, Mass.-based medical device company’s temperature regulating device is designed to control high fevers in patients with neurological impairment. It provides direct cooling and warming to the circulatory system via a ballon catheter.